Anca Maras, MD | |
1800 E Florence Blvd, Casa Grande, AZ 85222-5303 | |
(520) 381-6559 | |
(520) 381-6019 |
Full Name | Anca Maras |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Location | 1800 E Florence Blvd, Casa Grande, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548212459 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 13103 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anca Maras, MD Po Box 29211, Phoenix, AZ 85038-9211 Ph: (602) 273-6770 | Anca Maras, MD 1800 E Florence Blvd, Casa Grande, AZ 85222-5303 Ph: (520) 381-6559 |
News Archive
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, has signed an exclusive distribution agreement with Asahi Intecc Co., Ltd., based in Japan, to market its peripheral guide wire line in the United States.
Secretary of State Hillary Clinton's recent speech calling for an "AIDS-free generation" through the use of multiple prevention strategies, including more widespread antiretroviral therapy, "was a dramatic reversal of U.S. policy, which has historically viewed treatment more as a costly expense rather than our most powerful prevention investment," physician Loretta Ciraldo and Katrina Ciraldo, a student at Boston University School of Medicine, write in this Miami Herald opinion piece.
Bioxodes SA, a company developing products derived from natural sources, has completed a EUR 2.6 million (USD 3.5 million) first seed funding round with a consortium of business angels and Belgian investment funds. EUR 1.6 million is from the European Regional Development Fund and the Walloon Region in Belgium via the Retech program for Research and Technology. It will be used to bring the company's lead product Ir-CPI into pre-clinical development over the next 18 months.
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
› Verified 3 days ago
Dr. George Roger Edelen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1653 E Mcmurray Blvd, Suite 144, Casa Grande, AZ 85122 Phone: 520-836-8644 Fax: 520-836-2499 | |
Paul Madejski, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1800 E Florence Blvd, Casa Grande, AZ 85222 Phone: 520-426-6300 | |
Philip Kapsos, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1800 E Florence Blvd, Casa Grande, AZ 85222 Phone: 520-426-6300 |